Aethlon Medical Inc EBITDA margin
Cos'è EBITDA margin di Aethlon Medical Inc?
EBITDA margin di Aethlon Medical Inc è -951.91%
Qual è la definizione di EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin di aziende nel Industrials settore su NASDAQ rispetto a Aethlon Medical Inc
Cosa fa Aethlon Medical Inc?
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
Aziende con ebitda margin simili a Aethlon Medical Inc
- Abilene Oil and Gas ha EBITDA margin di -961.72%
- Plaza Centers N.V ha EBITDA margin di -960.71%
- HeraMED ha EBITDA margin di -959.06%
- Sealand Capital Galaxy ha EBITDA margin di -957.69%
- StrikeForce Technologies ha EBITDA margin di -956.58%
- Land & Homes ha EBITDA margin di -955.69%
- Aethlon Medical Inc ha EBITDA margin di -951.91%
- Thomson Resources Ltd ha EBITDA margin di -950.96%
- Kitov Pharma Ltd ha EBITDA margin di -945.60%
- Resonant Inc ha EBITDA margin di -944.32%
- Microvision ha EBITDA margin di -942.18%
- Cara Therapeutics Inc ha EBITDA margin di -941.75%
- Torchlight Resources Inc ha EBITDA margin di -933.70%